| Issue |
Section |
Title |
File |
| Vol 17, No 3 (2020) |
Reviews |
T2 asthma and T2-associated diseases: a consolidated approach to biological therapy |
(Rus)
(Eng)
|
| Vol 17, No 3 (2020) |
Help to the practitioner |
Efficacy and safety of the antileukotriene drugs: relevant data. RAACI experts conclusion |
(Rus)
|
| Vol 17, No 4 (2020) |
Help to the practitioner |
Vitamin D and chronic spontaneous urticaria: searching for algorithms of personalized therapy |
(Rus)
(Eng)
|
| Vol 20, No 2 (2023) |
Clinical practice guidelines |
Leukotriene receptor antagonists in the treatment of bronchial asthma: Consensus agreement “Bronchial Asthma and LEukoTriene receptor antagonists (BALET)” |
(Rus)
|
| Vol 22, No 2 (2025) |
Reviews |
Current aspects of the use of allergen-specific immunotherapy in patients with bronchial asthma: review of GINA 2024 updates and results of the EfficAPSI study |
(Rus)
|
| Vol 22, No 2 (2025) |
Reviews |
Clinical efficacy and safety of fixed-dose intranasal combination of azelastine hydrochloride and fluticasone propionate for treatment of seasonal allergic rhinitis |
|
| Vol 22, No 2 (2025) |
Letters to the editor |
The past, present, and future of anti-IgE therapy |
(Rus)
|
| Vol 22, No 2 (2025) |
Reviews |
Approach to choosing antihistamines for treatment of itchy dermatoses |
|
| Vol 22, No 4 (2025) |
Original studies |
Effect of combined nasal spray of olopatadine hydrochloride and mometasone furoate on the control of allergic rhinitis and concomitant allergic asthma in children |
(Rus)
|
